
Omar K. Abughanimeh, MBBS
Advertisement
Articles by Omar K. Abughanimeh, MBBS


This study explores the efficacy and safety of combining docetaxel and capecitabine for treating recurrent or metastatic head and neck cancer.
Advertisement
Latest Updated Articles
A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and NeckPublished: August 13th 2025 | Updated:
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLCPublished: October 30th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer
2
FDA Accepts NDA for Gedatolisib in HR+/HER2–, PIK3CA Wild-Type Breast Cancer
3
Firmonertinib Demonstrates Promise in EGFR+ Advanced/Metastatic NSCLC
4
FDA Accepts NDA for Bezuclastinib Combo in Gastrointestinal Stromal Tumors
5

